Buyer Name: Ministry of Defence
Buyer Address: Army Headquarters, Marlborough Lines, Andover, UKJ36, SP11 8HJ, United Kingdom
Contact Name: Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk
Contact Email: Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk
Buyer Name: Ministry of Defence
Buyer Address: Army Headquarters, Marlborough Lines, Andover, UKJ36, SP11 8HJ, United Kingdom
Contact Name: Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk
Contact Email: Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk
The Armed Forces Compulsory Drug Testing Programme is the largest occupational drug-testing programme in Europe and was established in January 1995. It is designed to reduce the incidence of substance misuse in the Armed Forces by detection and deterrence underpinned by education and policy. Currently between 100,000 - 125,000 samples are collected per annum. In addition to testing for drug misuse, there is also the requirement for the contractor to conduct screening for steroids and new psychoactive substances. The programme involves the analysis of urine samples of service personnel. Samples are collected by Armed Forces collection teams and transported to the laboratory of the Authority's urinalysis contractor. The programme also requires research and scientific support. These areas are included in this contract, which is structured to provide maximum flexibility to cope with change during its life.
No linked documents found for this notice.
External Link: https://www.find-tender.service.gov.uk/Notice/063967-2025
Link Description: Tender notice on Find a Tender
Lot 1 Status: active
Lot 1 Value: GBP 15,000,000
Lot 1 Value (Gross): GBP 18,000,000
Lot 1 Contract Start: 2026-04-01T00:00:00+01:00
Lot 1 Contract End: 2031-03-31T23:59:59+01:00
Lot 1 SME Suitable: Yes
Lot 1 Award Criterion (quality): Tehcnical requirements
Lot 1 Award Criterion (quality): Social Value
Lot 1 Award Criterion (cost): Total value of Tender including extensions
Document Description: Not published
Document Description: Tender notice on Find a Tender
{
"buyer": {
"id": "GB-PPON-PHVX-4316-ZVGZ",
"name": "Ministry of Defence"
},
"date": "2025-10-10T08:22:13+01:00",
"id": "063967-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-051776",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Andover",
"postalCode": "SP11 8HJ",
"region": "UKJ36",
"streetAddress": "Army Headquarters, Marlborough Lines"
},
"contactPoint": {
"email": "Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk",
"name": "Army-Comrcl-Procure-HC-Mailbox@mod.gov.uk"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.gov.uk/government/organisations/ministry-of-defence"
},
"id": "GB-PPON-PHVX-4316-ZVGZ",
"identifier": {
"id": "PHVX-4316-ZVGZ",
"scheme": "GB-PPON"
},
"name": "Ministry of Defence",
"roles": [
"buyer"
]
}
],
"tag": [
"tender"
],
"tender": {
"aboveThreshold": true,
"awardPeriod": {
"endDate": "2026-01-15T23:59:59+00:00"
},
"description": "The Armed Forces Compulsory Drug Testing Programme is the largest occupational drug-testing programme in Europe and was established in January 1995. It is designed to reduce the incidence of substance misuse in the Armed Forces by detection and deterrence underpinned by education and policy. Currently between 100,000 - 125,000 samples are collected per annum. In addition to testing for drug misuse, there is also the requirement for the contractor to conduct screening for steroids and new psychoactive substances.\nThe programme involves the analysis of urine samples of service personnel. Samples are collected by Armed Forces collection teams and transported to the laboratory of the Authority\u0027s urinalysis contractor.\nThe programme also requires research and scientific support. These areas are included in this contract, which is structured to provide maximum flexibility to cope with change during its life.",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
},
{
"datePublished": "2025-10-10T08:22:13+01:00",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"format": "text/html",
"id": "063967-2025",
"noticeType": "UK4",
"url": "https://www.find-tender.service.gov.uk/Notice/063967-2025"
}
],
"enquiryPeriod": {
"endDate": "2025-10-16T18:00:00+01:00"
},
"hasRecurrence": true,
"id": "714890452",
"items": [
{
"additionalClassifications": [
{
"description": "Urologist services",
"id": "85121292",
"scheme": "CPV"
},
{
"description": "Drug detection apparatus",
"id": "38544000",
"scheme": "CPV"
},
{
"description": "Laboratory services",
"id": "71900000",
"scheme": "CPV"
},
{
"description": "Analysers",
"id": "38434000",
"scheme": "CPV"
},
{
"description": "Health services",
"id": "85100000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "Please see attached DEFFORM 47 ITT",
"name": "Tehcnical requirements",
"type": "quality"
},
{
"description": "Please see attached DEFFORM 47 ITT",
"name": "Social Value",
"type": "quality"
},
{
"description": "Total value of Tender including extensions priced in accodordance with Variation of Price, please see tender documents, VOP can be seen at condition 47.4 of the terms and conditions (SC2)",
"name": "Total value of Tender including extensions",
"type": "cost"
}
],
"weightingDescription": "The Tender Evaluation will calculated using the Value for Money Index which is a Most Advantageous Tender (MAT) Evaluation\nThis approach divides the total score of the non-cost (quality) criteria by the tender cost. It ranks tenders on the quality (represented by the non-cost score) for each \u00a3 (or \u00a3k or \u00a3m) of costs."
},
"contractPeriod": {
"endDate": "2031-03-31T23:59:59+01:00",
"startDate": "2026-04-01T00:00:00+01:00"
},
"id": "1",
"selectionCriteria": {
"criteria": [
{
"description": "Turnover\t\nThe Authority will review each Potential Provider Entity\u2019s turnover for the three full financial years prior to the date of the ITT. If the estimated annual contract value for this procurement exceeds fifty per cent. (50%) of a Potential Provider\u0027s annual turnover, the Potential Provider will not meet this qualification standard. \nWhere the Potential Provider Entity intends to provide all or some of of the required services via a joint-venture company, Consortium Member, or other special purpose vehicle, the Authority will apply the assessment equally to the Potential Provider Entity.\nAccordingly, where the annual contract value turnover exceeds 50% of the value of a Potential Provider Entity turnover (assessed as the cumulation of all parties turnover in either the joint venture, Consortia or special purpose vehicle), the Potential Provider Entity will not meet this qualification standard.\nLiquidity ratios\t\nA Potential Provider Entity\u2019s current assets are divided by current liabilities to establish if there are sufficient assets to cover all of the Potential Provider Entity\u2019s liabilities as they fall due over the course of one year. \tThe Authority requires a Potential Provider Entity to have:\na minimum current ratio of 1.0; and\na minimum acid test ratio of 0.8.\nIf these ratios are not met, the Potential Provider Entity will not meet this qualification standard. \nCompany Watch\t\nCompany Watch \"H-Score\" (an overall measure of a business\u0027 financial health \u2013 for more information, see www.companywatch.net/analytics-insight/h-score). If a Potential Provider Entity does not have a score of 20 or above, the Potential Provider Entity will not meet this qualification standard. \nWhere Company Watch \u201cH-Score\u201d is unavailable or for international companies, Net Debt/EBITDA (below) will be used as an alternative. \nNet Debt/EBITDA\tAn entity\u2019s EBITDA is a proxy for the cash flow it generates from its ongoing operations. The Net Debt to EBITDA Ratio measures an entity\u2019s ability to service its debt.\t\nThe Authority requires a Potential Provider Entity to have:\na maximum of 2.5x\nIf this ratio is not met, the Potential Provider Entity will not meet this qualification standard.",
"type": "economic"
},
{
"description": "Tenderers must be UKAS accredited or demonstrate ability to gain UKAS accredication to the satisfaction of the Authority by the contract start date.",
"type": "technical"
}
]
},
"status": "active",
"suitability": {
"sme": true,
"vcse": true
},
"value": {
"amount": 15000000,
"amountGross": 18000000,
"currency": "GBP"
}
}
],
"mainProcurementCategory": "services",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"recurrence": {
"dates": [
{
"startDate": "2030-12-02T23:59:59+00:00"
}
]
},
"status": "active",
"submissionMethodDetails": "Please submit response on the Defence Sourcing Portal via the following link: https://contracts.mod.uk/go/2210270901999AC76049",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"tenderPeriod": {
"endDate": "2025-11-04T11:00:00+00:00"
},
"title": "Provision of Armed Forces Compulsory Drug Testing UK4",
"value": {
"amount": 15000000,
"amountGross": 18000000,
"currency": "GBP"
}
}
}